Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Castillo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|September 26, 2014
The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregationIryna Benilova, Rodrigo Gallardo, Andreea-Alexandra Ungureanu, et al.
Cancers|February 11, 2023
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor TissueMarie-Eve Beaulieu, Sandra Martínez-Martín, Jastrinjan Kaur, et al.
The EMBO Journal|April 1, 2021
Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcriptionPaola Pellanda, Mattia Dalsass, Marco Filipuzzi, et al.
Journal of Clinical Medicine|April 30, 2021
Lack of Social Support and Its Role on Self-Perceived Health in a Representative Sample of Spanish Adults. Another Aspect of Gender InequalityJulia Wärnberg, Napoleón Pérez-Farinós, María Julia Ajejas-Bazán, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.
Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.
Cell Reports|November 22, 2025
MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancerFabio Giuntini, Íñigo González-Larreategui, Andrea Herencia-Ropero, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|September 26, 2014
The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregationIryna Benilova, Rodrigo Gallardo, Andreea-Alexandra Ungureanu, et al.
Cancers|February 11, 2023
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor TissueMarie-Eve Beaulieu, Sandra Martínez-Martín, Jastrinjan Kaur, et al.
The EMBO Journal|April 1, 2021
Integrated requirement of non-specific and sequence-specific DNA binding in Myc-driven transcriptionPaola Pellanda, Mattia Dalsass, Marco Filipuzzi, et al.
Journal of Clinical Medicine|April 30, 2021
Lack of Social Support and Its Role on Self-Perceived Health in a Representative Sample of Spanish Adults. Another Aspect of Gender InequalityJulia Wärnberg, Napoleón Pérez-Farinós, María Julia Ajejas-Bazán, et al.
Nature Medicine|February 6, 2024
MYC targeting by OMO-103 in solid tumors: a phase 1 trialElena Garralda, Marie-Eve Beaulieu, Víctor Moreno, et al.
Cancer Research Communications|March 2, 2023
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and SeedingDaniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, et al.
Science Translational Medicine|March 22, 2019
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapyMarie-Eve Beaulieu, Toni Jauset, Daniel Massó-Vallés, et al.
Cell Reports|November 22, 2025
MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancerFabio Giuntini, Íñigo González-Larreategui, Andrea Herencia-Ropero, et al.
Pageof 2